Inhaled corticosteroids and COVID-19 morbidity: Nationwide cohort study

Study identification

• EU PAS number:
  EUPAS35897
• Study ID:
  39968
• Official title and acronym:
  Inhaled corticosteroids and COVID-19 morbidity: Nationwide cohort study
• DARWIN EU® study:
  No
• Study countries:
  Denmark
• Study description:
  Study of corticosteroids in COVID-19 in comparison with influenza.
• Study status:
  Finalised

Research institutions and networks

Institutions

Department of Epidemiology Research, Statens Serum Institut

Denmark

Pharmacoepi center, University of Southern Denmark

Denmark

Statens Serum Institut Copenhagen, Denmark

Study timelines

Date when funding contract was signed

Actual:06/07/2020

Study start date

Actual:06/07/2020

Data analysis start date

Actual:06/07/2020

Date of final study report

Planned:03/08/2020

Actual:11/03/2021

Sources of funding

Other

More details on funding

Various Research councils

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable